Vivoryon Therapeutics NV (FRA:05Y) Interest Expense : €-0.06 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vivoryon Therapeutics NV's interest expense for the six months ended in Dec. 2023 was € 0.27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.06 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vivoryon Therapeutics NV's Operating Income for the six months ended in Dec. 2023 was € -18.10 Mil. Vivoryon Therapeutics NV's Interest Expense for the six months ended in Dec. 2023 was € 0.27 Mil. Vivoryon Therapeutics NV did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vivoryon Therapeutics NV Interest Expense Historical Data

The historical data trend for Vivoryon Therapeutics NV's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivoryon Therapeutics NV Interest Expense Chart

Vivoryon Therapeutics NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.02

-0.06

Vivoryon Therapeutics NV Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.11	0.08	-0.33	0.27

Vivoryon Therapeutics NV Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.06 Mil.

Vivoryon Therapeutics NV (FRA:05Y) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vivoryon Therapeutics NV's Interest Expense for the six months ended in Dec. 2023 was €0.27 Mil. Its Operating Income for the six months ended in Dec. 2023 was €-18.10 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €0.00 Mil.

Vivoryon Therapeutics NV's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Vivoryon Therapeutics NV (FRA:05Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

VVY:Netherlands

Address

Weinbergweg 22, Halle, SN, DEU, 06120

Website

https://www.vivoryon.com

Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV (FRA:05Y) Headlines

No Headlines